Literature DB >> 33645945

Recognition of thrombotic risk of thrombocytosis in iron deficiency

Hanny Al-Samkari1, Craig M Kessler2, Michael Auerbach2.   

Abstract

Entities:  

Year:  2021        PMID： 33645945      PMCID： PMC7927881          DOI： 10.3324/haematol.2020.270496

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Clinical update: intravenous iron for anaemia.

Authors:  Michael Auerbach; Harold Ballard; John Glaspy
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

Review 2.  The safety of intravenous iron preparations: systematic review and meta-analysis.

Authors:  Tomer Avni; Amir Bieber; Alon Grossman; Hefziba Green; Leonard Leibovici; Anat Gafter-Gvili
Journal:  Mayo Clin Proc       Date:  2014-10-30       Impact factor: 7.616

3.  Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.

Authors:  David H Henry; Naomi V Dahl; Michael A Auerbach
Journal:  Am J Hematol       Date:  2012-01-20       Impact factor: 10.047

4.  The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.

Authors:  M Loo; Y Beguin
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

5.  Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia.

Authors:  Andrew B Song; David J Kuter; Hanny Al-Samkari
Journal:  Am J Hematol       Date:  2020-07-03       Impact factor: 10.047

6.  Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

Authors:  David H Henry; Naomi V Dahl; Michael Auerbach; Simon Tchekmedyian; Leslie R Laufman
Journal:  Oncologist       Date:  2007-02

Review 7.  Iron deficiency anemia: a common and curable disease.

Authors:  Jeffery L Miller
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

8.  Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.

Authors:  Elisabeth R Pomp; Saskia le Cessie; Frits R Rosendaal; Carine J M Doggen
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

9.  Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats.

Authors:  Kristine Jimenez; Florentina Leitner; Aran Leitner; Gisela Scharbert; Philipp Schwabl; Anne-Margarethe Kramer; Anita Krnjic; Joachim Friske; Thomas Helbich; Rayko Evstatiev; Vineeta Khare; Christoph Gasche
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

10.  A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.

Authors:  Pere Gascón; Rajnish Nagarkar; Martin Šmakal; Konstantinos N Syrigos; Carlos H Barrios; Jesús Cárdenas Sánchez; Li Zhang; David H Henry; David Gordon; Vera Hirsh; Kaoru Kubota; Sergey Orlov; Gary Thomas; Tilman Steinmetz; Jin-Hyoung Kang; Dianne K Tomita; Alexander N Fleishman; Joseph K Park; Cisio De Oliveira Brandao
Journal:  J Thorac Oncol       Date:  2019-10-16       Impact factor: 15.609
  10 in total
  1 in total

Review 1.  Iron deficiency anemia and thrombosis risk in children-revisiting an old hypothesis.

Authors:  Hannah Kalff; Holger Cario; Susanne Holzhauer
Journal:  Front Pediatr       Date:  2022-08-01       Impact factor: 3.569
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.